TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: H3 K27M mutation status prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Serum CTX levels at end of pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum P1NP concentrations postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensitivity of RASM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of RASM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of ROC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in PANSS total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in CGI-S scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytochrome C protein content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dizziness handicap score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activities-specific balance confidence change scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unintentional injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation rate in CRC screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disclosure of HIV status to a partner
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Ureteral injury rate
Endpoint domain: Adverse events/effects
Primary endpoint: Pathologic response in melanoma lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction of APH risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathologic response of the ILN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived fullness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean change in BCVA from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: central subfield thickness (CSFT) <280 µm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of ocular serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Mean increase in weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean increase in length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to neutrophil recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to platelet recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early allograft dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: nosocomial infection rates
Endpoint domain: Adverse events/effects
Primary endpoint: percentage of patients who experienced nausea on POD3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: nausea score on POD3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: number of spontaneous bowel movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinical pregnancy outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Resistive index in the left capsular artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: First-shock success rate for ventricular arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Procedural-related adverse event rate
Endpoint domain: Adverse events/effects
Primary endpoint: 5-year biochemical control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean AUA scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean EPIC scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: White Blood Cells (WBCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Procalcitonin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of patients revisiting ED within 48-72 hours
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: semiannual HCC surveillance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous clearance of NG infections
Endpoint domain: Adverse events/effects
Primary endpoint: lymphocyte percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: neutrophil percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Patient-reported outcome measure (PROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial energy expenditure (REE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Health-related outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adverse experiences with PRP
Endpoint domain: Adverse events/effects
Primary endpoint: Bone Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone Volume/Tissue Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Δ ARV 24‐h‐DBP (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean L-value of WSL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of duodenoscopes with ATP ≥ 40 RLUs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BC rate
Endpoint domain: Adverse events/effects
Primary endpoint: Separation Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Problem behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory factor levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial blood gas index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRQOL (FACT‐B+4 total score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Lymphedema prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ankle-specific function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Android fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self-paced gait speed (nTUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fast-paced gait speed (fTUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of new CES-D-10 scores of 8 or more
Endpoint domain: Adverse events/effects
Primary endpoint: DVT rate on Doppler ultrasonography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: incomplete graft attachment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: need for rebubbling
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: HbA1c value >10%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LDL cholesterol level >100 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: BP levels >140/90 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intestinal background volume reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor contrast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in 25OHD concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Uptake of communication knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Recognition of skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Expectation of skill adoption by students
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative nausea and vomiting (PONV) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Primary incision healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Inability to advance catheter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of epidural needle manipulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chemotherapy modifications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adrenaline concentration after six months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Adrenaline reactivity after six months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Low Frequency band after six months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean maximum cumulative tolerated dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DBPCFC reaction severity (symptom score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean postoperative distance-corrected intermediate visual acuity at 60 cm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of UI severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Physical health-related quality of life (HRQoL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Access to improved water sources
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Access to improved sanitation facilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Water satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Discharge on the proposed day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative sevoflurane dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak NRS score in the PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL‐6 concentration at 2 h after incision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving female range testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Static lung compliance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adhesive defects at interfaces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for recognizing AG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for recognizing GIM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measure of Audiologic Rehabilitation Self‐efficacy for Hearing Aids
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perceived choice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: core muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VOM ethanol infusion success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arrhythmia recurrence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of delayed tamponade
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of asymptomatic SARS-CoV-2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: nighttime sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Progression to high-grade dysplasia/esophageal adenocarcinoma
Endpoint domain: Mortality/survival
Primary endpoint: Use of adaptive emotion regulation strategies
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tolerability of metformin dose
Endpoint domain: Adverse events/effects
Primary endpoint: Time of first need for morphine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS scores for visceral pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Offspring BMD at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General understanding of date labels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sleep status (Richards-Campbell sleep scale)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of cases that needed mechanical ventilation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Anastomotic stricture occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Median treatment duration
Endpoint domain: Resource use
Primary endpoint: Percentage of time in the optimal SpO2 range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of individuals achieving AHI <10 events/h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: principal diagnosis clinician severity rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postpartum vaginal pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain medication utilized
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Abdominal aortic aneurysm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Missed school
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Serum amyloid protein (SAP) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tissue necrosis factor α (TNF‐α) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical outcomes at day 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of head turns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Velocity of head turns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of head turns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glucose CV improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: median time to passage of stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Anaesthesia recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction of ulcer diameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bilateral punching time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: increased self-efficacy in cardiac care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 50% responder rates
Endpoint domain: Adverse events/effects
Primary endpoint: 100% responder rates
Endpoint domain: Adverse events/effects
Primary endpoint: seizure freedom
Endpoint domain: Adverse events/effects
Primary endpoint: ODI response rate
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: urine specific gravity (USG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urine color
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low-Density Lipoprotein Cholesterol (LDLc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of NNRTI TDRM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median CD4+ cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Platelet transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathogens detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Results-directed therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median mid-facial mucosal margin change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean PES scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SND development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: RRD (Relative Risk Difference)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total daily insulin dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Acute PVI rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until occurrence of ERAF
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease of ≥30% in abdominal pain, discomfort, or bloating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving ≥3 CSBMs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Composite endpoint of cardiovascular mortality, non-fatal myocardial infarction, or non-fatal stroke
Endpoint domain: Mortality/survival
Primary endpoint: Immediate learning outcomes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Learning outcomes at six months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: PICS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cost-effectiveness (ICER)
Endpoint domain: Resource use
Primary endpoint: New diagnoses of AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of correct responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: reaction times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: PACU stay time
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Desire to Drink
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Slowness to Eat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Food Fussiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time needed to perform each exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative respiratory failure risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Delivery of pre-hospital emergency anaesthesia (PHEA)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: memory ability changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total RDQ score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total symptom score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution rates of pruritus, otorrhea, aural fullness, tinnitus and hypoacusis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total Lequesne index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived Stress Scale (PSS) improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: complete clinical remission rate at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACR CRISS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: consumption of rescue medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Assessment of reasonable drug treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Inter-rater agreement on drug treatment quality
Endpoint domain: Adverse events/effects
Primary endpoint: Mean total score on testing modules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Health related quality of life (HrQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean free sugar intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Attitudes toward care seeking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Beliefs toward care seeking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: serum neurotrophin-3 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes